Prevalence and treatment of depression in Parkinson's disease

Connie Veazey, Sahinde Ozlem Erden Aki, Karon F. Cook, Eugene C. Lai, Mark E. Kunik*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

143 Scopus citations


Parkinson's disease (PD) is a progressive neurological condition with debilitating symptoms, and depression is a common comorbid condition of this disease. The authors review existing literature on the prevalence and treatment of depression in PD. Prevalence estimates of depression vary widely, ranging from 7%-76%. This variation is due to inconsistent methodology. Treatment options for depression in PD include medication therapy, electroconvulsive therapy (ECT), and psychotherapy. There are few randomized controlled trials of these treatment options. The authors argue for more systematic and controlled research examining both the prevalence and treatment of depression in PD.

Original languageEnglish (US)
Pages (from-to)310-323
Number of pages14
JournalJournal of Neuropsychiatry and Clinical Neurosciences
Issue number3
StatePublished - Jan 1 2005

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health


Dive into the research topics of 'Prevalence and treatment of depression in Parkinson's disease'. Together they form a unique fingerprint.

Cite this